Tuesday, April 16, 2024
Home Client Page 3

Client

    Random
    Internet Stock Review

    Stocks On The Move!

    Client Editor / Curator -
    Citius (CTXR) up 19%, Draganfly (DFLYF) up 31%, urban-gro (UGRO) up 37%, Provention (PVRB) flip-flopping, Hapbee Technologies (HAPBF) up 26% and the...
    coronavirus, biotech stock review

    VIDEO: Dyadic (DYAI) CEO Explains What his Industry is Doing to Defeat Coronavirus (FoxNews).

    Biotech News Editor / Curator -
    Jan. 27, 2020 - 5:24 - Dyadic International CEO Mark Emalfarb discusses what’s being done to stop...

    The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...

    2022 Watch List Editor / Curator -
    The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21. Revive Therapeutics (RVTTF), RedHill BioPharma...
    Satori Capital. Hapbee

    Investment Manager With $1 Billion in Assets Under Management, Buys 300 Hapbee (HAPB) Head...

    Telehealth Editor / Curator -
    Things that make you go mmmm. Randy Eisenman is co-founder and managing partner of Satori Capital with more than...

    Make Hay While the Sun Shines. Up 6,400%.

    Biotech News Editor / Curator -
    Celcius (CELH) We're Up 6,400%. Alkaline Water (WTER) We're Up 12%.Dicerna (DRNA) We're Up 700%. Ready to Breakout?BioSig (BSGM) We Have...
    Revive Therapeutics

    Revive Therapeutics (RVVTF, RVV): Updates and News Archive.

    Client Editor / Curator -
    Recent Headlines (See FDA Filing Submission at Bottom) LIVE QUOTE

    Immunomedics (IMMU) $3.00 to $88, Up 29-fold, Our Second Best Idea Ever.

    2020 Watch List Editor / Curator -
    Interesting Charts From the Day we Discovered it. Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced...

    Zacks Research Update on Innovus Pharmaceutical (INNV).

    Research Editor / Curator -

    Kevin Harrington Presentation. (Video)

    Video Editor / Curator -
    The Three Strategies I've Used to Build Businesses. https://youtu.be/aNZAAKxPNlM Shark Tanks’ Kevin...
    Biotech Stock Review, DYAI

    Dyadic (DYAI) Scores $10M deal with Sorrento Therapeutics (SNRE).

    2020 Watch List Editor / Curator -
    Share Price up 27% ($4.63 up $1.04) as Wall Street Sorts out the Terms of the Deal. We've had...
    1234...36Page 3 of 36

    Latest article

    Major Mpox Outbreak in the Democratic Republic of Congo.

    Mpox Editor / Curator -
    As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...

    Mpox Infections Rise to Almost Double Last Year’s Numbers.

    All News Editor / Curator -
    The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of...

    Adding Asia Broadband (AABB) to Speculative Watch List.

    Client Editor / Curator -
    Asia Broadband, Gold Play With Digital Currency (NFT) Twist The last speculative stock trading under $0.05, that we...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.